Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer
Status:
Terminated
Trial end date:
2019-08-01
Target enrollment:
Participant gender:
Summary
This study will test if the use of DysportTM (abobotulinumtoxinA) improves wound healing and
scarring after Mohs surgery. Research in the laboratory as well as previous studies in humans
have shown improved wound healing and scarring with the use of a similar medication called
Botox.
Dysport may improve wound healing and scarring by relaxing facial muscles and therefore
minimizes the muscle tension and possibly the inflammation around the wound.
Phase:
Phase 4
Details
Lead Sponsor:
AboutSkin Dermatology and DermSurgery, PC University Hospitals Cleveland Medical Center
Collaborators:
Medicis Pharmaceutical Corporation University Hospitals Cleveland Medical Center
Treatments:
abobotulinumtoxinA Botulinum Toxins, Type A Hemagglutinins incobotulinumtoxinA onabotulinumtoxinA